| Active Not Recruiting | Emapalumab Treatment For Anticipated Clinical Benefit In Sepsis Driven By The Interferon-Gamma Endotype (The E Sepsis | Phase 2 | 2025-03-22 |
| Recruiting | The Incidence of Pulmonary, Cardiovascular and Renal System Non-communicable Complications Associated With the Pulmonary Complications, Cardiovascular Complications, Renal Complications | — | 2024-12-10 |
| Recruiting | Cardiovascular Disease Progression in Survivors of Community Acquired Pneumonia and Lung Infection by Covid-19 Pneumonia, Community-Acquired, COVID-19 Pneumonia, Cardiovascular Diseases | — | 2024-11-08 |
| Recruiting | Viscoelastic Coagulation for Early Sepsis Detection Infection, Sepsis | — | 2024-10-31 |
| Recruiting | Clarithromycin Treatment to Prevent Sepsis Progression in CAP (REACT) Community-acquired Pneumonia | Phase 3 | 2024-02-12 |
| Completed | NGS-Based Assay of Blood Samples of Sepsis Patients for Rapid Bacterial Identification Pneumonia, Acute Pyelonephritis, Bacteremia | — | 2023-11-16 |
| Active Not Recruiting | Assessing the Procalcitonin-guidance and Molecular-guided Diagnosis for Therapy of Severe Infections (the MODI Sepsis | Phase 3 | 2023-09-19 |
| Recruiting | Safety and Efficacy of Anakinra Treatment for Patients With Post Acute Covid Syndrome Post-Acute COVID-19 Syndrome, Post-Acute COVID-19, Long COVID | Phase 2 / Phase 3 | 2023-09-06 |
| Completed | Distinguishing Bacterial and Viral Infections by MeMed BV® Test to Limit Gut Colonization by MDRO Viral Infection, Bacterial Infections, Multi-antibiotic Resistance | — | 2023-05-29 |
| Completed | Use of Presepsin as a Marker for Immunotherapy Administration in Pneumonia Community-acquired Pneumonia, Hospital-acquired Pneumonia | Phase 2 | 2023-03-06 |
| Completed | Bezlotoxumab Yielded Outcomes by Addressing Personalized Needs in Clostridioides Difficile Infection Clostridioides Difficile Infection, Stool Microbiome, Organ Dysfunction Syndrome | Phase 2 | 2022-04-13 |
| Unknown | STS Administration on Coronavirus Disease (COVID-19) Patients in Critical Care COVID-19, Virus Diseases, Corona Virus Infection | Phase 2 | 2022-04-01 |
| Completed | Personalized Immunotherapy in Sepsis Sepsis | Phase 2 | 2021-07-29 |
| Completed | Addressing Personalized Needs in Clostridioides Difficile Infection Clostridioides Difficile Infection | N/A | 2021-01-26 |
| Completed | Anti-inflammatory Action of Oral Clarithromycin in Community-acquired Pneumonia Community-acquired Pneumonia, Sepsis, Inflammatory Response | Phase 3 | 2021-01-25 |
| Completed | suPAR-Guided Anakinra Treatment for Management of Severe Respiratory Failure by COVID-19 Covid19 | Phase 3 | 2020-12-23 |
| Completed | Bacillus Calmette-guérin Vaccination to Prevent COVID-19 COVID-19, Virus Diseases, Corona Virus Infection | Phase 4 | 2020-05-26 |
| Completed | Anti-inflammatory Clarithromycin for Improving COVID-19 Infection Early COVID-19, Virus Diseases, Corona Virus Infection | Phase 2 | 2020-05-06 |
| Completed | suPAR-guided Anakinra Treatment for Validation of the Risk and Management of Respiratory Failure by COVID-19 ( COVID-19, Virus Diseases, Corona Virus Infection | Phase 2 | 2020-04-15 |
| Completed | Personalised Immunotherapy for SARS-CoV-2 (COVID-19) Associated With Organ Dysfunction COVID-19, Virus Diseases, Macrophage Activation Syndrome | Phase 2 | 2020-04-02 |
| Unknown | Incretin Hormones in Type 1 Diabetes Mellitus;Effect of Metformin Treatment Type 1 Diabetes Mellitus | Phase 3 | 2019-11-29 |
| Completed | Pulse Photoplethysmography as an Early Tool for the Diagnosis of Sepsis Sepsis | — | 2019-10-30 |
| Completed | The Benefit of Bermekimab in Patients With Systemic Sclerosis Scleroderma, Systemic | Phase 2 | 2019-07-19 |
| Unknown | suPAR to Guide Antibiotics in Emergency Department Sepsis | Phase 2 / Phase 3 | 2018-10-27 |
| Completed | A Trial of Validation and Restoration of Immune Dysfunction in Severe Infections and Sepsis Sepsis, Macrophage Activation Syndrome | Phase 2 | 2017-12-15 |
| Completed | Benefit of Clarithromycin in Patients With Severe Infections Through Modulation of the Immune System Sepsis, Pneumonia, Gram-Negative Bacteria Infection | Phase 3 | 2017-12-15 |
| Completed | A Clinical Trial of Procalcitonin-guided Antimicrobial Therapy in Sepsis Sepsis | N/A | 2017-10-24 |
| Completed | Heparin Binding Protein in Early Sepsis Diagnosis Sepsis, Infection | N/A | 2017-09-22 |
| Completed | Bacillus Calmette-guérin Vaccination to Prevent Infections of the Elderly Infection, Hospitalization, Mortality | Phase 4 | 2017-09-21 |